Birgit Scheel

3.3k total citations
32 papers, 2.3k citations indexed

About

Birgit Scheel is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Birgit Scheel has authored 32 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 20 papers in Immunology and 6 papers in Oncology. Recurrent topics in Birgit Scheel's work include RNA Interference and Gene Delivery (21 papers), Immunotherapy and Immune Responses (17 papers) and Immune Response and Inflammation (7 papers). Birgit Scheel is often cited by papers focused on RNA Interference and Gene Delivery (21 papers), Immunotherapy and Immune Responses (17 papers) and Immune Response and Inflammation (7 papers). Birgit Scheel collaborates with scholars based in Germany, Norway and Switzerland. Birgit Scheel's co-authors include Steve Pascolo, Ingmar Hoerr, Jochen Probst, Hans‐Georg Rammensee, Benjamin Weide, Jean‐Philippe Carralot, Claus Garbe, Thomas Eigentler, Karl‐Josef Kallen and Mariola Fotin‐Mleczek and has published in prestigious journals such as Journal of Clinical Oncology, Molecular Microbiology and Annals of Oncology.

In The Last Decade

Birgit Scheel

32 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Birgit Scheel Germany 19 1.5k 1.2k 467 391 328 32 2.3k
Ann H. Rux United States 24 270 0.2× 481 0.4× 210 0.4× 117 0.3× 112 0.3× 35 1.5k
Sophie Iochmann France 21 493 0.3× 136 0.1× 82 0.2× 214 0.5× 117 0.4× 39 1.5k
Shaoheng Ni United States 23 1.3k 0.9× 287 0.2× 1.7k 3.6× 905 2.3× 470 1.4× 27 2.1k
Michael Niepmann Germany 29 1.7k 1.1× 337 0.3× 86 0.2× 46 0.1× 319 1.0× 44 2.7k
Xavier Paliard United States 22 360 0.2× 1.7k 1.4× 214 0.5× 270 0.7× 172 0.5× 33 2.6k
Massimo Gentile Italy 21 1.2k 0.8× 779 0.7× 57 0.1× 310 0.8× 359 1.1× 52 2.4k
Katherine Staskus United States 22 652 0.4× 700 0.6× 331 0.7× 1.4k 3.5× 994 3.0× 25 3.5k
Christoph Springfeld Germany 31 634 0.4× 359 0.3× 658 1.4× 2.2k 5.6× 249 0.8× 118 3.7k
José Menézes Canada 25 265 0.2× 1.1k 0.9× 158 0.3× 668 1.7× 323 1.0× 76 2.0k
Jacinto López‐Sagaseta Spain 16 282 0.2× 483 0.4× 38 0.1× 113 0.3× 118 0.4× 25 1.0k

Countries citing papers authored by Birgit Scheel

Since Specialization
Citations

This map shows the geographic impact of Birgit Scheel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Scheel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Scheel more than expected).

Fields of papers citing papers by Birgit Scheel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Scheel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Scheel. The network helps show where Birgit Scheel may publish in the future.

Co-authorship network of co-authors of Birgit Scheel

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Scheel. A scholar is included among the top collaborators of Birgit Scheel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Scheel. Birgit Scheel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hong, Henoch S., Sven D. Koch, Birgit Scheel, et al.. (2016). Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy. OncoImmunology. 5(12). e1249560–e1249560. 18 indexed citations
2.
Kübler, Hubert, Birgit Scheel, Ulrike Gnad-Vogt, et al.. (2015). Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study. Journal for ImmunoTherapy of Cancer. 3(1). 26–26. 211 indexed citations
3.
Kowalczyk, Aleksandra, Edith Jasny, Birgit Scheel, et al.. (2014). Self-adjuvanted RNActive® vaccine induces local immune responses at the injection site leading to potent adaptive immunity in mice and humans. Journal for ImmunoTherapy of Cancer. 2(S3). 1 indexed citations
4.
Heidenreich, Regina, Edith Jasny, Aleksandra Kowalczyk, et al.. (2014). A novel RNA‐based adjuvant combines strong immunostimulatory capacities with a favorable safety profile. International Journal of Cancer. 137(2). 372–384. 59 indexed citations
5.
Koch, Sven D., Henoch S. Hong, Susan Feyerabend, et al.. (2014). A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive®-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first results of the Phase I part. Journal for ImmunoTherapy of Cancer. 2(Suppl 3). P85–P85. 5 indexed citations
6.
7.
Kallen, Karl‐Josef, Regina Heidenreich, Margit Schnee, et al.. (2013). A novel, disruptive vaccination technology. Human Vaccines & Immunotherapeutics. 9(10). 2263–2276. 184 indexed citations
8.
Weide, Benjamin, Jean‐Philippe Carralot, Birgit Scheel, et al.. (2008). Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA. Journal of Immunotherapy. 31(2). 180–188. 203 indexed citations
9.
Scheel, Birgit, Steffen Aulwurm, Jochen Probst, et al.. (2006). Therapeutic anti‐tumor immunity triggered by injections of immunostimulating single‐stranded RNA. European Journal of Immunology. 36(10). 2807–2816. 93 indexed citations
10.
Probst, Jochen, Birgit Scheel, Ingmar Hoerr, et al.. (2006). Characterization of the ribonuclease activity on the skin surface. PubMed. 4(1). 4–4. 64 indexed citations
11.
Teufel, Regina, Jochen Probst, Birgit Scheel, et al.. (2005). Co-Transfection of Messenger RNA and siRNA as a Method to Study the Efficiency of siRNA. Nucleosides Nucleotides & Nucleic Acids. 24(2). 147–152. 2 indexed citations
12.
Scheel, Birgit, Regina Teufel, Jochen Probst, et al.. (2005). Toll‐like receptor‐dependent activation of several human blood cell types by protamine‐condensed mRNA. European Journal of Immunology. 35(5). 1557–1566. 168 indexed citations
13.
Skaane, Per, Arnulf Skjennald, K. C. Young, et al.. (2005). Follow-up and final results of the oslo I study comparing screen-film mammography and full-field digital mammography with soft-copy reading. Acta Radiologica. 46(7). 679–689. 40 indexed citations
14.
Carralot, Jean‐Philippe, Jochen Probst, Ingmar Hoerr, et al.. (2004). Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines. Cellular and Molecular Life Sciences. 61(18). 2418–2424. 113 indexed citations
15.
Scheel, Birgit, Jochen Probst, Jean‐Philippe Carralot, et al.. (2004). Immunostimulating capacities of stabilized RNA molecules. European Journal of Immunology. 34(2). 537–547. 112 indexed citations
16.
Hesketh, Andrew, Dominique Fink, Bertolt Gust, et al.. (2002). The GlnD and GlnK homologues of Streptomyces coelicolor A3(2) are functionally dissimilar to their nitrogen regulatory system counterparts from enteric bacteria. Molecular Microbiology. 46(2). 319–330. 79 indexed citations
17.
Jensenius, Mogens, et al.. (1995). [Extrapulmonary tuberculosis. An important differential diagnosis in immigrants with suspected malignancy].. PubMed. 115(27). 3365–8. 2 indexed citations
18.
Sandset, Per Morten, et al.. (1990). A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.. PubMed. 16 Suppl. 25–33. 83 indexed citations
19.
Holm, H.A., G.F. Handeland, Ulrich Abildgaard, et al.. (1986). Subcutaneous Heparin Treatment of Deep Venous Thrombosis: A Comparison of Unfractionated and Low Molecular Weight Heparin. Pathophysiology of Haemostasis and Thrombosis. 16(Suppl. 2). 30–37. 118 indexed citations
20.
Scheel, Birgit, et al.. (1985). Increased Detectability of Liver Metastases by the Use of Contrast Enhancement in Computed Tomography. Acta Radiologica Diagnosis. 26(4). 369–372. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann H. Rux Breakdown of academic impact, for papers by Sophie Iochmann Breakdown of academic impact, for papers by Shaoheng Ni Breakdown of academic impact, for papers by Michael Niepmann Breakdown of academic impact, for papers by Xavier Paliard Breakdown of academic impact, for papers by Massimo Gentile Breakdown of academic impact, for papers by Katherine Staskus Breakdown of academic impact, for papers by Christoph Springfeld Breakdown of academic impact, for papers by José Menézes Breakdown of academic impact, for papers by Jacinto López‐Sagaseta
Rankless by CCL
2026